
C21Insight subscribers.
You can access this subscription story - and hundreds more like them every month - for as little as £17/month.
CLICK HERE FOR MORE INFORMATION AND TO SUBSCRIBE
We'll email you a magic link to log in - no password required
For phone support, please call C21 on +44 (0) 20 7729 7460
1 x 90-minutes
The untold story of the fight for a female Viagra.
The Pink Pill: Sex, Drugs & Who Has Control tells the story of the ongoing fight to make sexual satisfaction a priority for women and gender diverse people in a biased battleground where much of their basic healthcare needs are under-researched, underfunded, and often outright ignored.
At the center of a medical battle is Cindy Eckert, a pharmaceutical entrepreneur who dared to challenge the regulatory system. Recognizable by her signature pink attire and unapologetic determination, Eckert became public enemy number one when she fought to bring Addyi—dubbed ""the female Viagra""—to market. After the FDA rejected the drug twice, Eckert boldly accused the agency of gender bias, ultimately securing approval in 2015 against overwhelming odds. Her battle turned into a billion-dollar sale of Addyi, but the struggle didn't end there.
The film reveals the shocking double standard in healthcare: while Viagra and over 20 medications for male sexual dysfunction sailed through approval in months, Eckert's battle for Addyi stretched over a decade, facing excessive restrictions and public vilification despite addressing a condition affecting millions of women.
Alongside Eckert, a new wave of trailblazers, doctors, scientists, and influencers are dismantling outdated norms and confronting the medical establishment's dismissal of female pleasure, and are forcing a shift in how we view sexual health for women and gender diverse people.
The Pink Pill: Sex, Drugs & Who Has Control captures a pivotal moment in the ongoing struggle for complete healthcare equality, at a time when bodily autonomy hangs in the balance.